Company Filing History:
2 out of 989 
2 out of 7 Years Active: 2019-2021
Title: Innovations by Toshihiro Nakajima
Introduction
Toshihiro Nakajima is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents to his name, Nakajima's work focuses on developing effective anticancer agents.
Latest Patents
His latest patents include an anticancer agent comprising HVJ-E and an immune checkpoint protein inhibitor. This invention provides a novel anticancer agent that combines HVJ-E (hemagglutinating virus of Japan envelope) with an inhibitor of an immune checkpoint protein. Another significant patent is an anti-cancer agent comprising HVJ-E and CXCL2. This invention presents a new anti-cancer agent that synergistically acts with HVJ-E, enhancing its effectiveness in cancer treatment.
Career Highlights
Throughout his career, Nakajima has worked with prestigious institutions, including Osaka University and Genomidea Inc. His research has focused on innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Some of his notable coworkers include Yasufumi Kaneda and Kazuma Sakura. Their collaborative efforts have contributed to the advancement of cancer research and the development of new therapeutic agents.
Conclusion
Toshihiro Nakajima's contributions to cancer research through his innovative patents highlight his commitment to finding effective treatments. His work continues to inspire advancements in the field of oncology.